[3] [4] These gastrointestinal symptoms can occasionally affect sleep quality, especially if nausea or discomfort occurs during the night
doi:10.3945/ajcn.2009.28834
In a 2018 study involving individuals with type 2 diabetes, both high (1 mg weekly) and low (0.5 mg weekly) doses of Ozempic demonstrated greater efficacy compared to Trulicity (dulaglutide), another GLP-1 agonist
FDA-approved GLP-1 receptor agonists undergo extensive manufacturing controls, stability testing, and quality assurance
These benefits are now also evident in people with obesity at high CVD risk (or with known vascular disease) but without T2D, as shown by the favorable effects of semaglutide in the Semaglutide Effects on Heart Disease and Stroke in Patients with Overweight or Obesity (SELECT) clinical trial 36
As weight loss care evolves, programs are no longer just about tracking food or counting points